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Abstract
Background: Thymic function is altered in HIV infection and characterized by dysregulation of the thymic
epithelial network, reduced thymic output and ultimately an impaired naïve T-cell pool. The IL-7/IL-7 receptor
(IL-7R) signalling pathway is critical for the maturation and differentiation of thymocytes. HIV infection is associated
with a decrease in IL-7Ra (CD127) expression and impaired CD127 signalling in circulating CD8
+ T-cells; however,
little is known about the effect of HIV on CD127 expression and IL-7 activity in the thymus. Therefore, the effect of
in vitro HIV infection on CD127 expression and IL-7-mediated function in thymocytes was investigated.
Findings: In vitro HIV infection of thymocytes did not affect CD127 expression on either total thymocytes or on
single positive CD4 or single positive CD8 subsets. However, HIV infection resulted in a decrease in the level of
IL-7-induced STAT-5 phosphorylation and Bcl-2 expression in unfractionated thymocytes.
Conclusion: These findings indicate that HIV infection alters IL-7 responsiveness of thymocytes by a mechanism
other than CD127 downregulation and potentially explain the disruption in thymopoiesis observed in HIV infection.
Findings
Human immunodeficiency virus (HIV) infection is char-
acterized by a loss of CD4
+ T-cells and a progressive loss
in cytotoxic T-cell lymphocyte (CTL) function resulting
in immunodeficiency. HIV infection has also been asso-
ciated with impaired thymic output [1]. Examination of
the thymus of HIV-infected pediatric patients reveals
selective thymocyte depletion and disruption of the thy-
mic microenvironment, which is thought to contribute to
more rapid progression to AIDS [2-4]. In HIV-1 infected
SCID-hu Thy/Liv mouse models, there is a depletion of
intrathymic progenitor T-cells which precedes the loss of
infected CD4
+CD8
+ thymocytes, suggesting that HIV
infection interrupts thymocyte development at an early
stage [5]. However, the mechanisms of disrupted thymic
development by HIV have yet to be fully elucidated.
Interleukin-7 (IL-7) is a pleiotropic cytokine that is cri-
tical for several stages of thymopoiesis, maintains mature
T-cell homeostasis, enhances CTL function and increases
T-cell survival [6-14]. IL-7 signals through the IL-7
receptor complex (IL-7R), which is composed of two sub-
units: the IL-7Ra chain (CD127), that is also shared by
TSLP [15], and the IL-2Rg chain which is shared by a
number of other cytokines including IL-2, IL-4, IL-9,
IL-15 and IL-21 [7,8]. The role of IL-7 in thymopoiesis is
multifaceted, as it is critical for early stages of T-cell
development in allowing chromatin accessibility to
enable T-cell receptor VDJ gene rearrangement, inducing
thymocyte proliferation and maintaining thymocyte sur-
vival by upregulating the anti-apoptotic protein Bcl-2 and
downregulating the pro-apoptotic protein Bax [12,16-18].
Disrupting IL-7 signalling can result in profoundly
impaired immunity as seen in patients with T
-B
+NK
+
Severe Combined Immunodeficiency (SCID), a genetic
defect that results in inactivation of the IL-7Ra signalling
pathway [19]. The importance of the IL-7 signalling com-
plex in thymic development was confirmed in knock-out
mice for both IL-7 and IL-7R. IL-7
-/- mice have a 20 fold
decrease in thymic cellularity and an increase in triple
negative (TN) cells, indicative of a developmental block
at the TN stage [20]. The phenotype with IL-7R
-/- knock-
out mice is much more severe with a 90-99.99% decrease
in thymic cellularity [13].
We and others have previously demonstrated that HIV
infection is associated with decreased CD127 expression
on circulating CD8
+ T-cells, and with effective antiretro-
viral therapy CD127 expression on T-cells is partially
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p l a yar o l ei nd i s e a s ep a t h o g e n e s i ss i n c et h ee x p r e s s i o n
of CD127 has been correlated with measures of disease
progression (decreased CD4 count, increased viral load,
increased immune activation) [24,25]. In addition to
decreased CD127 expression on T-cells, we and others
have also shown that CD127 signalling is impaired in
HIV infection [26-28]. Given the importance of the role
of IL-7 in HIV pathogenesis and the current develop-
ment of IL-7 as a therapeutic agent for HIV infection
and other conditions, understanding the mechanism by
which HIV impairs IL-7 activity within the thymus is of
the greatest importance. The aim of this study is to eval-
uate the effects of HIV infection on CD127 expression
and IL-7 activity in primary human thymocytes.
It has been widely reported that CD127 expression is
decreased on circulating CD4
+ and CD8
+ T-cells of HIV-
infected individuals [21-25]. We have also recently shown
that in vitro infection of peripheral blood mononuclear
cells (PBMC) results in decreased CD127 expression on
CD8
+ T-cells [29]. We therefore investigated the effect of
in vitro HIV infection on CD127 expression on thymo-
cytes as a potential mechanism of HIV-induced thymic
dysfunction. Thymocytes were infected in vitro with a pri-
mary isolate cs204 following previously described methods
[30,31]. Briefly unfractionated thymocytes were treated
with polybrene (3 μg/ml) (Sigma-Aldrich., Oakville, Ont)
for one hour prior to infection with the dual tropic strain
HIVcs204 at an M.O.I. of 0.01 or mock-infected with
equivalent volumes of PBMC culture supernatants. Two
hours post infection (p.i), cells were washed in phosphate
buffer saline (PBS) (Invitrogen, Burlington, On), resus-
pended to 1.0 × 10
6/ml and co-cultured with thymic
epithelial cells (TEC) (1:25) for up to 96 hours. CD127
expression on thymocytes was analysed every 24 h by flow
cytometry. Thymocytes were stained with the following
fluorochrome-conjugated monoclonal antibodies: CD3-
ECD (clone UCHT1), CD4-FITC (clone 13B8.2), CD8-
PC5 (clone B9.11), CD127-PE (clone R34.34) (all from
Beckman Coulter). The distribution of the following devel-
opmental stages of T-cell maturation was evaluated: (TN)
CD3-CD4-CD8-, (immature single positive CD4 ISP4+)
CD3-CD4+CD8-, (DP) CD3+/-CD4+CD8+ and (SP) CD4
+ or CD8+ cells. The gating strategy for phenotype analy-
sis is depicted in Figure 1A. There was no change in
CD127 expression on unfractionated thymocytes following
HIV infection over 96 hours in culture (Figure 1D).
Although HIV infection did not alter CD127 expression in
unfractionated thymocytes, a specific effect on individual
thymic subsets may have been masked. We, therefore,
infected total thymocytes and measured CD127 expression
on individual thymic subsets by flow cytometry. The thy-
mocyte subset distribution within the culture system
remained unchanged over a 96 hour culture period
regardless of HIV infection (data not shown). In vitro
HIVcs204 infection did not alter CD127 expression on
immature thymic subsets (i.e. TN, ISP4 and DP subsets;
data not shown) or on the more mature single positive
CD4
+ (SP4) or single positive CD8
+ (SP8) thymocytes
(Figure 1B-C).
To confirm HIV infection of thymocytes, genomic DNA
was isolated from infected thymocytes as early as 24 hours
and up to 96 hours p.i. Viral DNA was detectable by
nested PCR targeting the gag region of HIV (Figure 2).
Briefly, genomic DNA was isolated from infected thymo-
cytes using the QIAGEN DNeasy blood and tissue kit
(Qiagen, Mississauga, ON,). In the first round of PCR,
DNA (1/10) was amplified with outer P24 primers
(400 nm) forward (fwd): 5’-ATAGAGGAAGAGCAAAA-
CAAAA-3’; reverse (rvs): 5’-GTTCCTGAAGGGTAC-
TAGTAGT-3’. The second round PCR used 5 μlo ft h e
product from the first round of PCR with inner p24
primers (400 nm) fwd 5’-CAAAATTACCCTATAGTG
CA-3’ and rvs 5’-ATGTCACTTCCCCTTGGTT CT-3’.
Amplification conditions we r ea sf o l l o w s :2m i n u t e sa t
95°C, (94°C for 60 s, 55°C for 60 s and 72°C for 60 s) for
30 cycles and 7 minutes at 72°C.
While in vitro HIV infection did not affect surface
CD127 expression on thymocytes, it remains possible
that in vitro HIV infection is associated with altered IL-7
signalling as has been reported in CD8
+ T-cells from
HIV-infected individuals [26-28]. This was, therefore,
evaluated by measuring IL-7 responsiveness of thymo-
cytes following HIV infection. Thymocytes were infected
as described above, co-cultured with TEC for up to
96 hours and stimulated with IL-7 (1 ng/ml) (Sigma-
Aldrich Inc., Oakville Ont) (0-10 ng/ml) for 15 minutes
as previously described [32]. Cells were then fixed, per-
meabilized, stained with Alexa Fluor
® 488 mouse antihu-
man STAT5 pY694 (BD Biosciences, San Jose, CA, USA)
and analysed by flow cytometry. Thymocytes were cul-
tured with HIV for 24 hours in order to allow sufficient
time to establish infection. HIV had no impact on IL-7-
induced pSTAT-5 expression when evaluated 24 p.i.
(Figure 3A). However, thymocytes that were infected
with HIV and cultured for longer periods of time (96
hours) had lower levels of IL-7-induced pSTAT-5 com-
pared to mock-infected controls (Figure 3B). The change
in the level of STAT-5 phosphorylation was not due to
changes in cell viability, since there was no significant
difference in viability between HIV infected and mock
infected cultures after 96 hours of culture (data not
shown).
IL-7 signalling is known induce Bcl-2 expression in
thymocytes [33]. In order to further determine if in vitro
HIV infection alters IL-7 function, the level of IL-7-
induced Bcl-2 expression in HIV-infected thymocyte
cultures was measured. Twenty-four hours p.i., cells
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Figure 1 HIV infection does not alter CD127 expression on thymocytes. A) Unfractionated thymocytes (gate 1) were identified based on
the forward scatter/side scatter profiles of live cells. The cells were then gated on either CD3
- (gate 2) or CD3
+ (gate 3) in a single parameter
histogram. The cells in gate 2 and gate 3 were then analysed for CD4 and CD8 expression. The expression of CD127-PE (Beckman Coulter) was
measured on the various subsets. Thymocytes were incubated with HIVcs204 or mock infected and co-cultured with thymic epithelial cells for up
to 96 hours. Light grey lines represent isotype control, mock infected (black line) and HIV infected (dark grey line). B)SP4 subset C)SP8 subset.
Summary data of CD127 expression on thymocyte measured as the proportion of cells expressing CD127 relative to mock infected cultures on
D) unfractionated thymocytes, E) SP4, and F) SP8 thymic subsets.
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Page 3 of 6were washed and stimulated with IL-7 (0-10 ng/ml) for
48 hours as previously established for optimal Bcl-2
induction by IL-7 [34]. Cells were then fixed, permeabi-
lized, stained with Bcl-2-FITC (BD Bioscience) and ana-
lysed by flow cytometry. As expected, 48 hours of
stimulation with IL-7 resulted in increased Bcl-2 expres-
sion in unfractionated thymocytes. In vitro HIV infec-
tion resulted in a small but non-significant decrease of
constitutive Bcl-2 expression. Consistent with what was
seen with the effect on STAT-5 activation, infection
with HIVcs204 inhibited the ability of IL-7 to induce Bcl-
2 expression in thymocytes (Figure 4).
IL-7 also signals through the PI3K pathway leading to
cell proliferation and glucose uptake [35]. Thymocytes
were infected for up to 96 hours, serum starved for 2
hours and stimulated with IL-7 (10 ng/ml) for 1 hour.
Cells were lysed, and proteins were separated on an 8%
SDS-polyacrylamide gel and transferred to a nitrocellu-
lose membrane. Activation of the PI3K pathway was
visualised by probing the membranes with antibodies for
phosphorylated AKT (Cell Signalling, Danvers, MA). In
contrast to its effect on STAT-5 and Bcl-2, HIV infection
did not affect the ability of IL-7 to induce PI3K posphor-
ylation (data not shown).
The importance of IL-7 and its effect on thymopoiesis
are unequivocal. Disrupting this pathway leads to a block
in thymopoiesis and the arrest of T-cell development.
IL-7 signals through both the JAK/STAT and PI3K path-
ways to mediate cell survival, proliferation and differen-
tiation [35,36]. HIV infection both in vitro and in vivo is
associated with reduced CD127 on CD4
+ T-cells and
CD8
+ T cells [21-25]. We have, however, demonstrated
that in vitro HIV infection of thymocytes does not affect
the surface expression of CD127 on thymocytes. The
decreased CD127 expression on CD8
+ T-cells following
HIV-1 gag
E E-actin
HIV - +- +ACH2
24 h 96 h
H2O
Figure 2 Thymocytes are infected by HIV. Thymocytes were
incubated with HIVcs204, or mock infected and co-cultured with
thymic epithelial cells. DNA was isolated from the cells following 24
hours or 96 hours p.i and the presence of HIV-1 was measured by
nested PCR. As a positive control, DNA was isolated from ACH2
cells, and water was used as a negative control in the PCR reaction.
Results are representative of 3 separate experiments.
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Figure 3 The effect of in vitro HIV infection on IL-7-induced
STAT-5 phosphorylation in thymocytes. Thymocytes were
incubated with HIVcs204 or mock infected and co-cultured with
thymic epithelial cells. Following co-culture for A) 24 hours or B) 96
hours, thymocytes were stimulated with IL-7, and STAT-5
phosphorylation in the total thymocyte population was measured
by intracellular flow cytometry.
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Figure 4 The effect of HIV infection on the ability of IL-7 to
induced Bcl-2 expression in thymocytes. Thymocytes were
incubated with HIVcs204 or mock infected and co-cultured with
thymic epithelial cells for 24 hours. After 24 hours of culture,
thymocytes were stimulated with IL-7 for 48 hours, and Bcl-2
expression was measured by intracellular flow cytometry.
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Page 4 of 6in vitro HIV infection appears to be due to soluble factors
released in the culture microenvironment by PBMCs
[29]. Any such factors present in PBMC cultures may not
be present in thymocyte/TEC co-cultures, potentially
accounting for the differential effect of HIV on CD127
expression.
Although decreased IL-7 activity can result from
decreased receptor expression, a block in the IL-7 signal-
ling pathway may also result in altered IL-7 activity. This
phenomenon has been reported for IL-2 activity where
CD4
+ T-cells and CD8
+ T-cells from HIV
+ individuals are
less responsive to IL-2 compared to those from healthy
controls which has been attributed to a block in the JAK/
STAT pathway [37,38]. The results in this report indicate
that IL-7-induced STAT-5 phosphorylation and Bcl-2
expression are impaired in thymocyte cultures infected
with HIVcs204 while no effect on CD127 expression was
observed. This suggests that HIV infection results in a
block in the IL-7 pathway that occurs independent of its
effect on CD127 expression. These data support the find-
ings by Vranjkovic et al., which demonstrated reduced
IL-7 responsiveness in CD127-expressing CD8
+ T-cells
from HIV
+ patients. In that study, isolated CD8
+CD127
+
cells from HIV
+ individuals had lower levels of STAT-5
phosphorylation following IL-7 stimulation when com-
pared to those from uninfected controls [26]. Such a block
in IL-7 signalling has also been observed in other disease
states. For example, CD4
+ and CD8
+ T-cells isolated from
breast cancer patients are less responsive to IL-7, as mea-
sured by STAT-5 phosphorylation [39].
HIV may affect thymocyte function by altering the viabi-
lity of the cells, consequently lowering the output of func-
tional T-cells from the thymus [2,3,40,41]. In support of
this hypothesis, our data show that HIV infection inter-
feres with the ability of IL-7 to induce Bcl-2 expression. A
similar block in the ability of IL-7 to upregulate Bcl-2
expression was reported in a study in which CD4
+ T-cells
from HIV
+ individuals had lower levels of Bcl-2 expression
following IL-7 stimulation when compared to those from
healthy controls. That study found no correlation between
CD127 expression of CD4
+ T cells and IL-7 responsive-
ness, suggesting that the block in IL-7 activity was inde-
pendent of the level of CD127 expression [42].
T h ee x a c tm e c h a n i s mb yw h i c hH I Vi n t e r f e r e sw i t h
the IL-7 signalling pathway has yet to be determined,
however our results indicate that binding of HIV to the
cell surface is likely insufficient to mediate this effect
since there was no impact of HIV on IL-7 activity within
the first 24 hours of infection. Rather, our data demon-
strated that the cells need to be infected for longer peri-
ods of time (72-96 hours) for the effect of HIV to be
observed, suggesting that the mechanism of inhibition
might require the production of specific cellular or viral
factors.
In summary, we demonstrated that HIV infection
alters IL-7 activity in thymocytes independent of CD127
expression suggesting a potential mechanism by which
HIV infection interrupts thymic output and contributes
to immune deficiency.
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